Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1981 3
1982 4
1983 3
1985 2
1986 3
1987 3
1988 2
1989 3
1990 3
1991 8
1992 1
1993 2
1994 4
1995 5
1996 8
1997 5
1998 6
1999 6
2000 10
2001 9
2002 20
2003 16
2004 27
2005 37
2006 27
2007 40
2008 37
2009 78
2010 60
2011 72
2012 84
2013 75
2014 109
2015 115
2016 136
2017 179
2018 215
2019 244
2020 315
2021 370
2022 442
2023 471
2024 236

Text availability

Article attribute

Article type

Publication date

Search Results

3,131 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG. Choueiri TK, et al. Among authors: xie r. Lancet Oncol. 2023 Mar;24(3):228-238. doi: 10.1016/S1470-2045(23)00049-9. Lancet Oncol. 2023. PMID: 36858721 Clinical Trial.
Effects of vaginal microbiota transfer on the neurodevelopment and microbiome of cesarean-born infants: A blinded randomized controlled trial.
Zhou L, Qiu W, Wang J, Zhao A, Zhou C, Sun T, Xiong Z, Cao P, Shen W, Chen J, Lai X, Zhao LH, Wu Y, Li M, Qiu F, Yu Y, Xu ZZ, Zhou H, Jia W, Liao Y, Retnakaran R, Krewski D, Wen SW, Clemente JC, Chen T, Xie RH, He Y. Zhou L, et al. Among authors: xie rh. Cell Host Microbe. 2023 Jul 12;31(7):1232-1247.e5. doi: 10.1016/j.chom.2023.05.022. Epub 2023 Jun 15. Cell Host Microbe. 2023. PMID: 37327780 Clinical Trial.
Liang Y, Zhang C, Xie R, Zhang G. Liang Y, et al. Among authors: xie r. J Allergy Clin Immunol. 2023 Jul;152(1):304-306. doi: 10.1016/j.jaci.2023.04.002. Epub 2023 May 5. J Allergy Clin Immunol. 2023. PMID: 37149806 No abstract available.
The episodic resurgence of highly pathogenic avian influenza H5 virus.
Xie R, Edwards KM, Wille M, Wei X, Wong SS, Zanin M, El-Shesheny R, Ducatez M, Poon LLM, Kayali G, Webby RJ, Dhanasekaran V. Xie R, et al. Nature. 2023 Oct;622(7984):810-817. doi: 10.1038/s41586-023-06631-2. Epub 2023 Oct 18. Nature. 2023. PMID: 37853121
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R, Liu YP, Xie YL, Lin C, Duan CY, Chen DP, Pan Y, Qi B, Zou X, Guo L, Cao JY, Zhang YN, Wang ZQ, Liu YL, Ouyang YF, Wen K, Yang Q, Xie RQ, Li HF, Duan XT, Ding X, Peng L, Chen SY, Liang JL, Feng ZK, Xia TL, Xie RL, Jiang R, Gu CM, Liu RZ, Sun R, Yang X, Liu LZ, Ling L, Liu Q, Ng WT, Hua YJ, Huang PY, Chen MY. You R, et al. Among authors: xie rq, xie rl. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. Lancet. 2023. PMID: 36842439 Clinical Trial.
Function of TRP channels in monocytes/macrophages.
Wu J, Li Z, Deng Y, Lu X, Luo C, Mu X, Zhang T, Liu Q, Tang S, Li J, An Q, Fan D, Xiang Y, Wu X, Hu Y, Du Q, Xu J, Xie R. Wu J, et al. Among authors: xie r. Front Immunol. 2023 Jun 19;14:1187890. doi: 10.3389/fimmu.2023.1187890. eCollection 2023. Front Immunol. 2023. PMID: 37404813 Free PMC article. Review.
Presynaptic glutamate receptors in nociception.
Xie RG, Xu GY, Wu SX, Luo C. Xie RG, et al. Pharmacol Ther. 2023 Nov;251:108539. doi: 10.1016/j.pharmthera.2023.108539. Epub 2023 Sep 30. Pharmacol Ther. 2023. PMID: 37783347 Review.
3,131 results